Skip to main content

Table 1 Response rate by age groups and prevalence of hr-HPV mRNA stratified by age groups

From: Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection

Age group

Hr-HPV positive samples

Hr-HPV negative samples

Total HPV-tested samples

HPV prevalence

 

n

%

n

%

n

%

%

≤39

1

1.3

11

1.5

12

1.5

8.3

40–49

12

15.2

73

10.2

85

10.7

14.1

50–59

16

20.3

170

23.7

186

23.4

8.6

60–69

40

50.6

375

52.3

415

52.1

9.6

70 and 71

10

12.7

88

12.3

98

12.3

10.2

Total

79

100

717

100

796

100

9.9

  1. Hr-HPV High risk Human Papillomavirus